Notify me when MANGROVE PARTNERS IM, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. | Common Stock | 6.15% | $2.98M | 2.53M | Mangrove Partners IM, LLC | 31 Dec 2024 | ||
| CHPG | ChampionsGate Acquisition Corp | Class A ordinary shares, par value $0.0001 per share | 5.71% | $4.94M | 492K | Mangrove Partners IM, LLC | 30 Sep 2025 | ||
| MREO | Mereo BioPharma Group plc | American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share | 4.9% | $80.2M | 39M | Mangrove Partners IM, LLC | 30 Sep 2025 | ||
| AOGO | AROGO CAPITAL ACQUISITION CORP. | Class A Common Stock, $0.0001 par value per share | 4.49% | $2.75M | 218K | Mangrove Partners IM, LLC | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|